Why the study?
Although there is a clear clinical association between autism and myotonic dystrophy, the molecular basis for this connection remains unknown.
Key points are not available for this paper at this time.
Population
DMPK-CTG expansion and Mbnl null mouse models
Design
Animal model study
Answers are grounded in this paper and cite their sources.
May explain myotonic dystrophy-autism overlap via MBNL; hypothesis-generating for repeat expansions in idiopathic ASD.
Genome-wide enrichment of gene-specific tandem repeat expansions has been linked to autism spectrum disorder. One such mutation is the CTG tandem repeat expansion in the 3' untranslated region of the DMPK gene, which is known to cause myotonic muscular dystrophy type 1. Although there is a clear clinical association between autism and myotonic dystrophy, the molecular basis for this connection remains unknown. Here, we report that sequestration of MBNL splicing factors by mutant DMPK RNAs with expanded CUG repeats alters the RNA splicing patterns of autism-risk genes during brain development, particularly a class of autism-relevant microexons. We demonstrate that both DMPK-CTG expansion and Mbnl null mouse models recapitulate autism-relevant mis-splicing profiles, along with social behavioral deficits and altered responses to novelty. These findings support our model that myotonic dystrophy-associated autism arises from developmental mis-splicing of autism-risk genes.
No takes yet. Share an insight, caveat, or question.
Sznajder et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: